SLC7A11 and cancer: Several studies have focused on the interaction between NRF2 and xCT, which is a transmembrane antiporter coded by the SLC7A11 gene, which is increased in several cancers and has been known to mediate the extrusion of glutamate and support the redox homeostasis [110,111,112].